CNCCENTENE CORP

NYSE centene.com


$ 78.16 $ 0.17 (0.22 %)    

Wednesday, 28-Aug-2024 15:59:57 EDT
QQQ $ 468.16 $ -5.41 (-1.13 %)
DIA $ 411.36 $ -1.55 (-0.38 %)
SPY $ 558.32 $ -3.26 (-0.58 %)
TLT $ 97.88 $ -0.12 (-0.12 %)
GLD $ 231.76 $ -1.64 (-0.7 %)
$ 78.17
$ 77.82
$ 78.15 x 100
$ 78.19 x 100
$ 77.50 - $ 78.42
$ 60.83 - $ 81.42
3,122,090
na
41.12B
$ 0.94
$ 14.57
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-25-2024 06-30-2024 10-Q
2 04-25-2024 03-31-2024 10-Q
3 02-20-2024 12-31-2023 10-K
4 10-23-2023 09-30-2023 10-Q
5 07-27-2023 06-30-2023 10-Q
6 04-25-2023 03-31-2023 10-Q
7 02-21-2023 12-31-2022 10-K
8 10-25-2022 09-30-2022 10-Q
9 07-26-2022 06-30-2022 10-Q
10 04-26-2022 03-31-2022 10-Q
11 02-22-2022 12-31-2021 10-K
12 10-26-2021 09-30-2021 10-Q
13 07-26-2021 06-30-2021 10-Q
14 04-27-2021 03-31-2021 10-Q
15 02-22-2021 12-31-2020 10-K
16 10-27-2020 09-30-2020 10-Q
17 07-28-2020 06-30-2020 10-Q
18 04-28-2020 03-31-2020 10-Q
19 02-18-2020 12-31-2019 10-K
20 10-22-2019 09-30-2019 10-Q
21 07-23-2019 06-30-2019 10-Q
22 04-23-2019 03-31-2019 10-Q
23 02-19-2019 12-31-2018 10-K
24 10-23-2018 09-30-2018 10-Q
25 07-24-2018 06-30-2018 10-Q
26 04-24-2018 03-31-2018 10-Q
27 02-20-2018 12-31-2017 10-K
28 10-24-2017 09-30-2017 10-Q
29 07-25-2017 06-30-2017 10-Q
30 04-25-2017 03-31-2017 10-Q
31 02-21-2017 12-31-2016 10-K
32 10-25-2016 09-30-2016 10-Q
33 07-26-2016 06-30-2016 10-Q
34 04-26-2016 03-31-2016 10-Q
35 02-22-2016 12-31-2015 10-K
36 10-27-2015 09-30-2015 10-Q
37 07-28-2015 06-30-2015 10-Q
38 04-28-2015 03-31-2015 10-Q
39 02-23-2015 12-31-2014 10-K
40 10-28-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barclays-maintains-overweight-on-centene-raises-price-target-to-98

Barclays analyst Andrew Mok maintains Centene (NYSE:CNC) with a Overweight and raises the price target from $90 to $98.

 expert-ratings-for-centene
Expert Ratings For Centene
08/19/2024 16:00:58

 cantor-fitzgerald-reiterates-overweight-on-centene-maintains-90-price-target

Cantor Fitzgerald analyst Sarah James reiterates Centene (NYSE:CNC) with a Overweight and maintains $90 price target.

 stephens--co-reiterates-equal-weight-on-centene-maintains-78-price-target

Stephens & Co. analyst Scott Fidel reiterates Centene (NYSE:CNC) with a Equal-Weight and maintains $78 price target.

 wells-fargo-maintains-overweight-on-centene-raises-price-target-to-93

Wells Fargo analyst Stephen Baxter maintains Centene (NYSE:CNC) with a Overweight and raises the price target from $81 to $93.

 deutsche-bank-maintains-hold-on-centene-raises-price-target-to-87

Deutsche Bank analyst George Hill maintains Centene (NYSE:CNC) with a Hold and raises the price target from $82 to $87.

 td-cowen-maintains-buy-on-centene-raises-price-target-to-89

TD Cowen analyst Gary Taylor maintains Centene (NYSE:CNC) with a Buy and raises the price target from $80 to $89.

 oppenheimer-maintains-outperform-on-centene-lowers-price-target-to-95

Oppenheimer analyst Michael Wiederhorn maintains Centene (NYSE:CNC) with a Outperform and lowers the price target from $110 ...

 wall-street-enjoys-late-week-rally-on-benign-inflation-data-dow-jones-eyes-best-session-of-2024-tech-unwinding-stalls-whats-driving-markets-friday

After a turbulent week in the markets, the bulls reclaimed dominance on Wall Street during Friday’s session, with indices and s...

 health-insurer-centenes-q2-premium-revenue-cushions-fall-in-medicaid-enrollment-raises-annual-outlook

Centene reported a 5.9% year-over-year increase in second-quarter sales to $39.84 billion, beating the $36.46 billion consensus...

Core News & Articles

Expands Payer-Agnostic Care Delivery Capabilities Serving Over 129,000 Beneficiaries Across 17 StatesExpands Payer-Agnostic Car...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION